LONDON (Thomson Financial) - AOI Medical Inc said the US Food and Drug Administration has asked the company to conduct a clinical study of its BAMF (Balloon Assisted Management of Spine Fractures) Spine technology. The medical device company said it is currently negotiating the full details of the content and timing of the study.
